Sakar Healthcare Limited
NSE: SAKAR | Information Technology
Market Fundamentals
Stock Intelligence & News
Sakarni Plaster to invest Rs 450 cr on expansion; to set up 2 building material plants
Sakarni Plaster has announced an ambitious plan to invest Rs 450 crore over the next two years. This investment will focus on establishing new manufacturing facilities for gypsum boards and paints, while also expanding the capacities of existing plants to cater to rising demand. The funding will be sourced from internal accruals and bank loans, reinforcing the company's strategy to consolidate its market position in India's building materials sector.
Read Full Analysis →Narendra Properties Ltd (531416)
At the meeting o the Board of Directors held on 11.08.2026, the board approved (a) Payment of Remuneration to Mr. Nishank Sakariya, Non Executive Director as a Consultant from 01.01.2027 to 31.12.2027 (b) Payment of consultancy fees to Mr. Narendra C Maher, Promoter from 01.01.2027 to 31.12.2027 (c) Payment of consultancy fees to Mr. Narendra Sakariya, Promoter from 01.01.2027 to 31.12.2027 (d) Reappointment of Ms. Kavita Patel as Independent Director for a further period of 5 years from 27.12.2026 to 26.12.2031 (e) Authorization to make investment, loans and guarantees beyond limits u/s 186 of Companies Act 2013 up to a sum of Rs. 50 crores
Read Full Analysis →Sakar Healthcare Limited
Sakar Healthcare Limited has informed the Exchange about Transcript of Con-Call. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Sakar Healthcare Limited
Sakar Healthcare Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation
Read Full Analysis →350% rally in five years! Multibagger stock jumps after reporting 120% YoY rise in net profit during Q1FY27
Sakar Healthcare share price opened at ₹817.45 apiece today, as compared to the previous close of ₹802.20. The stock touched an intraday high of ₹833.90 apiece on 27 July.
Read Full Analysis →Sakar Healthcare Limited
Board Meeting Intimation |Meeting Date: 24-Jul-2026
Read Full Analysis →Sakar Healthcare Limited
Financial Results |Meeting Date: 24-Jul-2026
Read Full Analysis →Sakar Healthcare Limited
Sakar Healthcare Limited has informed the Exchange about Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 30th June 2026 |SUBJECT: General Updates
Read Full Analysis →Sakar Healthcare Limited
The Exchange had sought clarification from Sakar Healthcare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed. |SUBJECT: Reply to Clarification- Financial results
Read Full Analysis →Sakar Healthcare Limited
Sakar Healthcare Limited has informed the Exchange about Sakar enters it s 40th agreement signed with Zydus Lifesciences to cater oncology products to GCC and other emerging markets, in parallel to building momentum on strong execution and expanding Business Opportunities |SUBJECT: General Updates
Read Full Analysis →Get instant alerts when SAKAR breaks news
Join investors who track Sakar Healthcare Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for SAKAR?
SAKAR is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Sakar Healthcare Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding SAKAR to your custom watchlist.